NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Samhi Hotels Research Report

Summary

We have revised our estimates for Samhi Hotels, increasing our EBITDA projections by approximately 4% over the next two years. This upward revision is driven by the expected launch of RARE India, a luxury hospitality platform, which will generate new revenue streams and result in B2C commission income of Rs425mn and Rs556mn for FY27E and FY28E, respectively.

Key Developments

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

The affiliation with Marriott is expected to boost occupancy rates by 35-45% and average room rates (ARR) to Rs25,000 across existing properties. Furthermore, the strong parentage of Marriott will facilitate the onboarding of new owners, resulting in additional listings on the platform. Following the acquisition of RARE India, we anticipate revenue and EBITDA compound annual growth rates (CAGR) of 15% and 23%, respectively, from FY26E to FY28E.

Recommendation

We maintain a BUY rating on Samhi Hotels with a target price of Rs264, based on an earnings multiple of 10.5x FY28E EBITDA (previously 12x).

Investor Takeaway

Investors should consider maintaining a buy rating for Samhi Hotels with a target price of Rs 264.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.